FDA

Lilly
Pharma

Lilly nabs weekly insulin nod from FDA in new challenge to Novo

After notching approvals overseas, Lilly’s once-weekly insulin is coming home to open a new front in the company’s ongoing market showdown with Novo.
Fraiser Kansteiner Sep 25, 2026 8:57am
Magnifying glass with pills on blue

Regulatory tracker: AZ continues Breztri's asthma expansion

Sep 24, 2026 10:00am
drug recall FDA recall recall voluntary recall

Otsuka venture yanks sodium chloride for IV over labeling issue

Sep 24, 2026 9:41am
FDA

Bausch & Lomb gets FDA warning letter for contamination concerns

Sep 17, 2026 9:36am
Curium

FDA approves first radioligand equivalent

Sep 15, 2026 8:38am
FDA

New FDA oncology chief sets priorities in first interview

Sep 11, 2026 4:00am